Structures of N-terminally processed KRAS provide insight into the role of N-acetylation.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 07 2019
Historique:
received: 16 10 2018
accepted: 04 07 2019
entrez: 21 7 2019
pubmed: 22 7 2019
medline: 3 11 2020
Statut: epublish

Résumé

Although post-translational modification of the C-terminus of RAS has been studied extensively, little is known about N-terminal processing. Mass spectrometric characterization of KRAS expressed in mammalian cells showed cleavage of the initiator methionine (iMet) and N-acetylation of the nascent N-terminus. Interestingly, structural studies on GDP- and GMPPNP-bound KRAS lacking the iMet and N-acetylation resulted in Mg

Identifiants

pubmed: 31324887
doi: 10.1038/s41598-019-46846-w
pii: 10.1038/s41598-019-46846-w
pmc: PMC6642148
doi:

Substances chimiques

KRAS protein, human 0
Guanosine Diphosphate 146-91-8
Guanylyl Imidodiphosphate 34273-04-6
HRAS protein, human EC 3.6.5.2
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2
Magnesium I38ZP9992A

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

10512

Subventions

Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NIGMS NIH HHS
ID : P41 GM103403
Pays : United States

Références

EMBO J. 1998 Jul 1;17(13):3651-9
pubmed: 9649435
J Biol Chem. 2005 Sep 2;280(35):31267-75
pubmed: 15994326
Biophys J. 2012 Jul 18;103(2):293-302
pubmed: 22853907
Biochemistry. 2018 Jan 23;57(3):324-333
pubmed: 29235861
J Biol Chem. 2011 Nov 11;286(45):39644-53
pubmed: 21930707
Proteomics. 2015 Jul;15(14):2385-401
pubmed: 25914051
J Biol Chem. 2000 Jun 16;275(24):18311-7
pubmed: 10748207
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44
pubmed: 20124693
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Sci Rep. 2015 Nov 02;5:15916
pubmed: 26522388
Elife. 2013 Sep 10;2:e01456
pubmed: 24040512
J Biol Chem. 2000 Nov 24;275(47):36479-82
pubmed: 11013267
J Cell Sci. 2016 Apr 1;129(7):1287-92
pubmed: 26985062
J Biol Chem. 2005 Jul 8;280(27):25697-705
pubmed: 15878843
J Cell Biol. 2012 Jan 23;196(2):189-201
pubmed: 22270915
Proteins. 2005 Jun 1;59(4):687-96
pubmed: 15815974
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Bioinformatics. 2015 Apr 15;31(8):1325-7
pubmed: 25505092
PLoS One. 2015 Nov 11;10(11):e0142674
pubmed: 26560143
Trends Biochem Sci. 1998 Jul;23(7):263-7
pubmed: 9697417
Nat Rev Drug Discov. 2016 Nov;15(11):771-785
pubmed: 27469033
EMBO J. 1990 Aug;9(8):2351-9
pubmed: 2196171
Biochemistry. 1997 Jul 29;36(30):9109-19
pubmed: 9230043
Cell. 2004 Oct 29;119(3):393-405
pubmed: 15507210
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6766-E6775
pubmed: 27791178
Biochim Biophys Acta Proteins Proteom. 2017 Nov;1865(11 Pt B):1564-1576
pubmed: 28716441
J Biol Chem. 2010 Jul 16;285(29):22696-705
pubmed: 20479006
Protein Expr Purif. 2011 Apr;76(2):238-47
pubmed: 21146612
J Am Chem Soc. 2005 Nov 2;127(43):15127-37
pubmed: 16248653
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
Bio Protoc. 2018 Apr 5;8(7):
pubmed: 29951569
Crit Rev Biochem Mol Biol. 2015 Mar-Apr;50(2):85-133
pubmed: 25830673
Protein Sci. 2018 Jan;27(1):112-128
pubmed: 28836357
Cell Mol Life Sci. 2004 Jun;61(12):1455-74
pubmed: 15197470
EMBO Rep. 2001 Mar;2(3):234-8
pubmed: 11266366
Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):4140-4145
pubmed: 29610327
Proc Natl Acad Sci U S A. 2013 May 14;110(20):8182-7
pubmed: 23630290
Biophys J. 2019 Mar 19;116(6):1049-1063
pubmed: 30846362
J Cell Sci. 2005 Mar 1;118(Pt 5):843-6
pubmed: 15731001
Mol Cell Proteomics. 2013 Jan;12(1):14-28
pubmed: 23001859
Anal Biochem. 2001 Mar 1;290(1):126-37
pubmed: 11180946
Biochemistry. 1996 Aug 13;35(32):10308-20
pubmed: 8756686
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):4944-9
pubmed: 11320243
J Biol Chem. 1993 Jan 15;268(2):923-9
pubmed: 8419371
Methods Mol Biol. 2017;1586:65-82
pubmed: 28470599
Cell. 2017 Jun 29;170(1):17-33
pubmed: 28666118
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Cancer Discov. 2019 Jun;9(6):738-755
pubmed: 30952657
Biomol NMR Assign. 2013 Oct;7(2):215-9
pubmed: 22886485
Nature. 1998 Jul 23;394(6691):337-43
pubmed: 9690470
Biochemistry. 1994 Mar 29;33(12):3515-31
pubmed: 8142349

Auteurs

Srisathiyanarayanan Dharmaiah (S)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.

Timothy H Tran (TH)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.

Simon Messing (S)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.

Constance Agamasu (C)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.

William K Gillette (WK)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.

Wupeng Yan (W)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.

Timothy Waybright (T)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.

Patrick Alexander (P)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.

Dominic Esposito (D)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.

Dwight V Nissley (DV)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.

Frank McCormick (F)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.
Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, 94158, USA.

Andrew G Stephen (AG)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA.

Dhirendra K Simanshu (DK)

NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, 21701, USA. dhirendra.simanshu@fnlcr.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH